Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo

Journal of Virology
H HiraragiMichael D Lairmore

Abstract

Human T-lymphotropic virus type 1 (HTLV-1), the etiological agent of adult T-cell leukemia, encodes unique regulatory and accessory proteins in the pX region of the provirus, including the open reading frame II product p13(II). p13(II) localizes to mitochondria, binds farnesyl pyrophosphate synthetase, an enzyme involved in posttranslational farnesylation of Ras, and alters Ras-dependent cell signaling and control of apoptosis. The role of p13(II) in virus infection in vivo remains undetermined. Herein, we analyzed the functional significance of p13(II) in HTLV-1 infection. We compared the infectivity of a human B-cell line that harbors an infectious molecular clone of HTLV-1 with a selective mutation that prevents the translation of p13(II) (729.ACH.p13) to the infectivity of a wild-type HTLV-1-expressing cell line (729.ACH). 729.ACH and 729.ACH.p13 producer lines had comparable infectivities for cultured rabbit peripheral blood mononuclear cells (PBMC), and the fidelity of the start codon mutation in ACH.p13 was maintained after PBMC passage. In contrast, zero of six rabbits inoculated with 729.ACH.p13 cells failed to establish viral infection, whereas six of six rabbits inoculated with wild-type HTLV-1-expressing cells (729....Continue Reading

References

Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·L WillemsR Kettmann
Mar 14, 1998·Journal of Virology·P KerkhofsL Willems
May 3, 2000·AIDS Research and Human Retroviruses·W J MileyD Waters
Nov 18, 2000·AIDS Research and Human Retroviruses·D M D'AgostinoV Ciminale
Jul 5, 2002·Journal of Virology·Laurent LefèbvreRichard Kettmann
Nov 1, 2003·Advances in Cancer Research·Genoveffa FranchiniJulie M Johnson
Dec 4, 2003·Current Opinion in Cell Biology·Pablo M IrustaJ Marie Hardwick
Jan 20, 2004·Nature Medicine·Christophe NicotGenoveffa Franchini
Mar 27, 2004·FEBS Letters·Sabine ThébaultJean-Michel Mesnard
Apr 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Micol Silic-BenussiVincenzo Ciminale
Sep 11, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Michael BindhuMichael D Lairmore
Dec 4, 2004·Biochimica Et Biophysica Acta·Patricia BoyaGuido Kroemer
Mar 12, 2005·Cell Death and Differentiation·D M D'AgostinoV Ciminale
Sep 13, 2005·Oncogene·William W Hall, Masahiro Fujii
Sep 13, 2005·Oncogene·Christophe NicotGenoveffa Franchini

❮ Previous
Next ❯

Citations

Oct 7, 2006·Journal of Clinical Immunology·Hongwei ShaoAnlong Xu
Mar 27, 2007·Nature Reviews. Cancer·Masao Matsuoka, Kuan-Teh Jeang
Feb 16, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jill VanmassenhoveFadi Fakhouri
Feb 2, 2008·Retrovirology·James M Bogenberger, Paul J Laybourn
May 26, 2010·Infectious Agents and Cancer·Valeria BergonziniGiorgio Palù
Sep 19, 2007·International Journal of Hematology·Yorifumi Satou, Masao Matsuoka
Oct 14, 2011·Viruses·Dustin EdwardsGenoveffa Franchini
Oct 14, 2011·Viruses·Michael D LairmorePatrick L Green
May 7, 2009·Future Microbiology·Chloé JournoRenaud Mahieux
Aug 15, 2014·Frontiers in Microbiology·Vincenzo CiminaleMaria G Romanelli
Jun 19, 2015·PLoS Pathogens·Mowgli HolmesPaul D Bieniasz
Jul 24, 2012·Current Opinion in Virology·Michael D LairmoreRajaneesh Anupam
Dec 9, 2009·Expert Review of Anti-infective Therapy·Péter BagossiJózsef Tözsér
Oct 4, 2019·JCI Insight·Jingyu XiangKatherine N Weilbaecher
Apr 5, 2018·Frontiers in Microbiology·Anurag Kulkarni, Charles R M Bangham
May 14, 2020·Retrovirology·Maria OmslandGenoveffa Franchini
Aug 9, 2019·Retrovirology·Michael P MartinezPatrick L Green
Feb 23, 2018·Frontiers in Microbiology·Ilaria CavallariVincenzo Ciminale
Aug 8, 2021·International Journal of Molecular Sciences·Greta ForlaniMaria Grazia Romanelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis